These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9082727)

  • 1. [The molecular parameters of a meningococcal serogroup B protein-polysaccharide vaccine].
    Bobyleva GV; Artiukhova II; Kuvakina VI; Basnak'ian IA
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (5):39-43. PubMed ID: 9082727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the effectiveness of group-A and -C meningococcal polysaccharide vaccines by molecular parameters].
    Bobyleva GV; Kuvakina VI; Valerius II
    Antibiot Med Biotekhnol; 1987 Oct; 32(10):758-63. PubMed ID: 3122649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neisseria meningitidis serogroup C polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent meningococcus vaccine candidate.
    Fukasawa LO; Gorla MC; Schenkman RP; Garcia LR; Carneiro SM; Raw I; Tanizaki MM
    Vaccine; 1999 Aug; 17(23-24):2951-8. PubMed ID: 10462229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of meningococcal group B vaccine candidates: capsular or noncapsular?
    Diaz Romero J; Outschoorn IM
    Clin Microbiol Rev; 1994 Oct; 7(4):559-75. PubMed ID: 7834605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The immunological activity of a meningococcal serogroup-B polysaccharide-protein vaccine with a prolonged storage time in single administration].
    Basnak'ian IA; Alliluev AP; Kuvakina VI; Aleksakhina NN; Kotel'nikova OV; Chulok TA; Karabak Vi; Borovkova VM; Valerius II; Gofman IL
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):66-7. PubMed ID: 7879546
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine.
    Rosenqvist E; Høiby EA; Bjune G; Aase A; Halstensen A; Lehmann AK; Paulssen J; Holst J; Michaelsen TE; Nøkleby H; Frøholm LO; Closs O
    Dev Biol Stand; 1998; 92():323-33. PubMed ID: 9554288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of the conditions for Neisseria meningitidis cultivation on the protein composition in the protein-polysaccharide complex--the base of meningococcal serogroup B vaccine].
    Kuvakina VI; Basnak'ian IA; Aleksakhina NN; Artiukhova II; Bobyleva GV; Omarova SM
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (2):60-3. PubMed ID: 8701659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sensitive method for the determination of the molecular size of meningococcal polysaccharide vaccine.
    Helting TB; Kumpe M
    J Biol Stand; 1978; 6(2):111-5. PubMed ID: 418071
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer membrane protein conjugate vaccine.
    Weinberg GA; Einhorn MS; Lenoir AA; Granoff PD; Granoff DM
    J Pediatr; 1987 Jul; 111(1):22-7. PubMed ID: 3110388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.
    Noronha CP; Struchiner CJ; Halloran ME
    Int J Epidemiol; 1995 Oct; 24(5):1050-7. PubMed ID: 8557439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The dynamics of immunoglobulin E in volunteers immunized with a meningococcal group-B polysaccharide-protein vaccine].
    Gervazieva VB; Basnak'ian IA; Aleksakhina NN; Karabak VI; Borovkova VM; Kolenko VM; Chulok TA; Sveranovskaia VV
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):71-2. PubMed ID: 7879551
    [No Abstract]   [Full Text] [Related]  

  • 13. Production, characterization and control of MenB-vaccine "Folkehelsa": an outer membrane vesicle vaccine against group B meningococcal disease.
    Fredriksen JH; Rosenqvist E; Wedege E; Bryn K; Bjune G; Frøholm LO; Lindbak AK; Møgster B; Namork E; Rye U
    NIPH Ann; 1991 Dec; 14(2):67-79; discussion 79-80. PubMed ID: 1812438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of conjugate vaccines consisting of pneumococcal capsular polysaccharide types 6B, 14, 19F, and 23F and a meningococcal outer membrane protein complex.
    Vella PP; Marburg S; Staub JM; Kniskern PJ; Miller W; Hagopian A; Ip C; Tolman RL; Rusk CM; Chupak LS
    Infect Immun; 1992 Dec; 60(12):4977-83. PubMed ID: 1452327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The reactogenicity and antigenic activity of a meningococcal group B vaccine made from a natural complex of the specific polysaccharide and outer membrane proteins].
    Basnak'ian IA; Alliluev AP; Kuvakina VI; Levina LA; Krasnoproshina LI; Kotel'nikova OV; Karabak VI; Mordvitskiĭ AM; Borovkova VM; Aleksakhina NN
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Dec; (12):50-5. PubMed ID: 2129147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogenic in man.
    Zollinger WD; Mandrell RE; Griffiss JM; Altieri P; Berman S
    J Clin Invest; 1979 May; 63(5):836-48. PubMed ID: 109466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunity against Neisseria meningitidis in different population groups].
    Pauste Ruiz H; García Imia L; Campa Huergo C; Gutiérrez Hernández M; Valcárcel Novo M
    Rev Cubana Med Trop; 1989; 41(1):135-47. PubMed ID: 2505344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against group B Neisseria meningitidis disease: preparation of soluble protein and protein-polysaccharide immunogens.
    Frasch CE; Peppler MS
    Infect Immun; 1982 Jul; 37(1):271-80. PubMed ID: 6809629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface polysaccharide of Moraxella non-liquefaciens identical to Neisseria meningitidis group B capsular polysaccharide. A chemical and immunological investigation.
    Bøvre K; Bryn K; Closs O; Hagen N; Frøholm LO
    NIPH Ann; 1983 Jun; 6(1):65-73. PubMed ID: 6413906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A comparative study of the immunogenicity of 2 group-B meningococcal vaccines in monkeys].
    Krasnoproshina LI; Kil'diushevskaia TV; Serova TA; Vlasov GS; Dzhikidze EK; Balaeva EIa; Voskanian NA; Alliluev AP; Kuvakina VI; Basnak'ian IA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Oct; (10):84-9. PubMed ID: 1963725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.